Cargando…
Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK
Macular dystrophies are a group of individually rare but collectively common inherited retinal dystrophies characterised by central vision loss and loss of visual acuity. Single molecule Molecular Inversion Probes (smMIPs) have proved effective in identifying genetic variants causing macular dystrop...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859292/ https://www.ncbi.nlm.nih.gov/pubmed/36672932 http://dx.doi.org/10.3390/genes14010191 |
_version_ | 1784874318804549632 |
---|---|
author | Mc Clinton, Benjamin Corradi, Zelia McKibbin, Martin Panneman, Daan M. Roosing, Susanne Boonen, Erica G. M. Ali, Manir Watson, Christopher M. Steel, David H. Cremers, Frans P. M. Inglehearn, Chris F. Hitti-Malin, Rebekkah J. Toomes, Carmel |
author_facet | Mc Clinton, Benjamin Corradi, Zelia McKibbin, Martin Panneman, Daan M. Roosing, Susanne Boonen, Erica G. M. Ali, Manir Watson, Christopher M. Steel, David H. Cremers, Frans P. M. Inglehearn, Chris F. Hitti-Malin, Rebekkah J. Toomes, Carmel |
author_sort | Mc Clinton, Benjamin |
collection | PubMed |
description | Macular dystrophies are a group of individually rare but collectively common inherited retinal dystrophies characterised by central vision loss and loss of visual acuity. Single molecule Molecular Inversion Probes (smMIPs) have proved effective in identifying genetic variants causing macular dystrophy. Here, a previously established smMIPs panel tailored for genes associated with macular diseases has been used to examine 57 UK macular dystrophy cases, achieving a high solve rate of 63.2% (36/57). Among 27 bi-allelic STGD1 cases, only three novel ABCA4 variants were identified, illustrating that the majority of ABCA4 variants in Caucasian STGD1 cases are currently known. We examined cases with ABCA4-associated disease in detail, comparing our results with a previously reported variant grading system, and found this model to be accurate and clinically useful. In this study, we showed that ABCA4-associated disease could be distinguished from other forms of macular dystrophy based on clinical evaluation in the majority of cases (34/36) |
format | Online Article Text |
id | pubmed-9859292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98592922023-01-21 Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK Mc Clinton, Benjamin Corradi, Zelia McKibbin, Martin Panneman, Daan M. Roosing, Susanne Boonen, Erica G. M. Ali, Manir Watson, Christopher M. Steel, David H. Cremers, Frans P. M. Inglehearn, Chris F. Hitti-Malin, Rebekkah J. Toomes, Carmel Genes (Basel) Article Macular dystrophies are a group of individually rare but collectively common inherited retinal dystrophies characterised by central vision loss and loss of visual acuity. Single molecule Molecular Inversion Probes (smMIPs) have proved effective in identifying genetic variants causing macular dystrophy. Here, a previously established smMIPs panel tailored for genes associated with macular diseases has been used to examine 57 UK macular dystrophy cases, achieving a high solve rate of 63.2% (36/57). Among 27 bi-allelic STGD1 cases, only three novel ABCA4 variants were identified, illustrating that the majority of ABCA4 variants in Caucasian STGD1 cases are currently known. We examined cases with ABCA4-associated disease in detail, comparing our results with a previously reported variant grading system, and found this model to be accurate and clinically useful. In this study, we showed that ABCA4-associated disease could be distinguished from other forms of macular dystrophy based on clinical evaluation in the majority of cases (34/36) MDPI 2023-01-11 /pmc/articles/PMC9859292/ /pubmed/36672932 http://dx.doi.org/10.3390/genes14010191 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mc Clinton, Benjamin Corradi, Zelia McKibbin, Martin Panneman, Daan M. Roosing, Susanne Boonen, Erica G. M. Ali, Manir Watson, Christopher M. Steel, David H. Cremers, Frans P. M. Inglehearn, Chris F. Hitti-Malin, Rebekkah J. Toomes, Carmel Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title | Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title_full | Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title_fullStr | Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title_full_unstemmed | Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title_short | Effective smMIPs-Based Sequencing of Maculopathy-Associated Genes in Stargardt Disease Cases and Allied Maculopathies from the UK |
title_sort | effective smmips-based sequencing of maculopathy-associated genes in stargardt disease cases and allied maculopathies from the uk |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859292/ https://www.ncbi.nlm.nih.gov/pubmed/36672932 http://dx.doi.org/10.3390/genes14010191 |
work_keys_str_mv | AT mcclintonbenjamin effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT corradizelia effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT mckibbinmartin effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT pannemandaanm effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT roosingsusanne effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT boonenericagm effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT alimanir effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT watsonchristopherm effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT steeldavidh effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT cremersfranspm effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT inglehearnchrisf effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT hittimalinrebekkahj effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk AT toomescarmel effectivesmmipsbasedsequencingofmaculopathyassociatedgenesinstargardtdiseasecasesandalliedmaculopathiesfromtheuk |